ABC - AmerisourceBergen Corporation
NYSE
->
Healthcare
->
Medical Distribution
Conshohocken,
United States
Type: Equity
ABC price evolution
ABC
| (in millions $) | 30 Jul 2023 | 31 Mar 2023 | 31 Jan 2023 | 30 Oct 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1389.35 | $1539.41 | $1692.2 | $3388.19 |
| Short term investments | ||||
| Net receivables | $20796.65 | $19491.1 | $20241.92 | $19984.74 |
| Inventory | $16852.34 | $16955.24 | $16779.87 | $15556.39 |
| Total current assets | $40986.58 | $39989.64 | $40708.13 | $39589.76 |
| Long term investments | ||||
| Property, plant & equipment | $2147.88 | $2149.94 | $2139.78 | $2135 |
| Goodwill & intangible assets | $14425.26 | $14518.38 | $13027.03 | $12836.62 |
| Total noncurrent assets | $20190.61 | $18776.54 | $17198.77 | $16970.86 |
| Total investments | ||||
| Total assets | $61177.2 | $58766.18 | $57906.89 | $56560.62 |
| Current liabilities | ||||
| Accounts payable | $43752.08 | $42734.82 | $41757.95 | $40192.89 |
| Deferred revenue | ||||
| Short long term debt | $860.86 | $266.28 | $988.27 | $1070.47 |
| Total current liabilities | $46783.21 | $45071.1 | $44760.62 | $43477.96 |
| Long term debt | $4159.85 | $4666.53 | $4656.03 | $4632.36 |
| Total noncurrent liabilities | $13471.94 | $13183.95 | $13072.71 | $13011.39 |
| Total debt | $5020.71 | $4932.81 | $5644.3 | $5702.83 |
| Total liabilities | $60255.15 | $58255.05 | $58085.02 | $56489.34 |
| Shareholders' equity | ||||
| Retained earnings | $4071.96 | $3691.31 | $3357.68 | $2977.65 |
| Other shareholder equity | -$1226.69 | -$1316.14 | -$1411.92 | $71.27 |
| Total shareholder equity | $686.02 | $281.69 | -$178.13 | -$211.56 |
| (in millions $) | 30 Oct 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $3388.19 | $2547.14 | $4597.75 | $3374.19 |
| Short term investments | ||||
| Net receivables | $19984.74 | $18167.17 | $13846.3 | $12386.88 |
| Inventory | $15556.39 | $15368.35 | $12589.28 | $11060.25 |
| Total current assets | $39589.76 | $38802.61 | $33055.7 | $28132.05 |
| Long term investments | ||||
| Property, plant & equipment | $2135 | $2162.96 | $1484.81 | $1770.52 |
| Goodwill & intangible assets | $12836.62 | $14287.46 | $8592.83 | $9000.34 |
| Total noncurrent assets | $16970.86 | $18535.2 | $11219.13 | $11039.93 |
| Total investments | ||||
| Total assets | $56560.62 | $57337.81 | $44274.83 | $39171.98 |
| Current liabilities | ||||
| Accounts payable | $40192.89 | $38009.95 | $31705.06 | $28385.07 |
| Deferred revenue | ||||
| Short long term debt | $1070.47 | $300.21 | $501.26 | $139.01 |
| Total current liabilities | $43477.96 | $41358.64 | $33853.08 | $29581.29 |
| Long term debt | $4632.36 | $6383.71 | $3618.26 | $4354.4 |
| Total noncurrent liabilities | $13011.39 | $15394.75 | $11261.39 | $6597.48 |
| Total debt | $5702.83 | $6683.92 | $4119.52 | $4493.41 |
| Total liabilities | $56489.34 | $56753.39 | $45114.47 | $36178.77 |
| Shareholders' equity | ||||
| Retained earnings | $2977.65 | $1670.51 | $518.34 | $4235.49 |
| Other shareholder equity | $71.27 | -$445.44 | -$108.83 | -$111.97 |
| Total shareholder equity | -$211.56 | $223.35 | -$1018.92 | $2878.92 |
| (in millions $) | 30 Jul 2023 | 31 Mar 2023 | 31 Dec 2022 | 30 Oct 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $63457.21 | $62846.83 | $61174.15 | |
| Cost of revenue | $61161.76 | $60700.88 | ||
| Gross Profit | $2295.44 | $2145.95 | $1985.56 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1321.09 | $1290.93 | ||
| Total operating expenses | $1734.92 | $1512.81 | $1434.02 | |
| Operating income | $560.52 | $633.14 | ||
| Income from continuing operations | ||||
| EBIT | $583.43 | $643.05 | ||
| Income tax expense | $83.92 | $117.28 | $83.66 | |
| Interest expense | $64.11 | $46.02 | -$51.52 | |
| Net income | ||||
| Net income | $435.4 | $479.75 | $294.74 | |
| Income (for common shares) | $435.4 | $479.75 | ||
| (in millions $) | 30 Oct 2022 | 31 Jan 2022 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $238587.01 | $189893.93 | $179589.12 | |
| Cost of revenue | $184702.04 | $174450.81 | ||
| Gross Profit | $8296.37 | $5191.88 | $5138.31 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $2767.22 | $2663.51 | ||
| Total operating expenses | $5542.86 | $10327.24 | $4026.39 | |
| Operating income | -$5135.35 | $1111.92 | ||
| Income from continuing operations | ||||
| EBIT | -$5165.11 | $1126.11 | ||
| Income tax expense | $516.52 | -$1894.27 | $112.97 | |
| Interest expense | -$210.67 | $137.88 | $157.77 | |
| Net income | ||||
| Net income | $1698.82 | -$3408.72 | $855.37 | |
| Income (for common shares) | -$3408.72 | $855.37 | ||
| (in millions $) | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 | 30 Oct 2022 |
|---|---|---|---|---|
| Net income | $479.58 | $435.4 | $479.75 | |
| Operating activities | ||||
| Depreciation | $105.67 | $101.34 | $100.33 | |
| Business acquisitions & disposals | $28.44 | -$1438.12 | ||
| Stock-based compensation | $20.57 | $23.5 | $55.63 | |
| Total cash flows from operations | $744.93 | $629.51 | $710.08 | |
| Investing activities | ||||
| Capital expenditures | -$104.28 | -$102.85 | -$75.73 | |
| Investments | -$737.02 | |||
| Total cash flows from investing | -$819.13 | -$88.74 | -$1511.16 | -$368.44 |
| Financing activities | ||||
| Dividends paid | -$98.93 | -$101.77 | -$99.71 | -$391.69 |
| Sale and purchase of stock | -$81.63 | $9.85 | -$785.35 | |
| Net borrowings | $103.54 | -$674.58 | -$10.52 | |
| Total cash flows from financing | -$81.87 | -$769.45 | -$963.94 | -$1752.78 |
| Effect of exchange rate | $15.66 | $4.68 | $84.14 | -$57.85 |
| Change in cash and equivalents | -$140.41 | -$223.99 | -$1680.88 | $523.41 |
| (in millions $) | 30 Oct 2022 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | $1539.93 | -$3408.72 | $855.37 | |
| Operating activities | ||||
| Depreciation | $326.71 | $290.74 | $321.1 | |
| Business acquisitions & disposals | -$5563.04 | -$63.95 | ||
| Stock-based compensation | $99.59 | $74.41 | $58.87 | |
| Total cash flows from operations | $2666.59 | $2207.04 | $2344.02 | |
| Investing activities | ||||
| Capital expenditures | -$423.78 | -$333.31 | -$310.22 | |
| Investments | -$162.62 | -$56.08 | ||
| Total cash flows from investing | -$368.44 | -$6141.58 | -$379.87 | -$375.83 |
| Financing activities | ||||
| Dividends paid | -$391.69 | -$366.65 | -$343.58 | -$338.97 |
| Sale and purchase of stock | $116.6 | -$194.56 | -$597.8 | |
| Net borrowings | $2216.55 | -$53.45 | -$133.07 | |
| Total cash flows from financing | -$1752.78 | $1952.85 | -$603.62 | -$1086.51 |
| Effect of exchange rate | -$57.85 | -$3.73 | ||
| Change in cash and equivalents | $523.41 | -$1527.62 | $1223.55 | $881.68 |
News
Fundamentals
| Market cap | $37.42B |
|---|---|
| Enterprise value | $41.05B |
| Shares outstanding | 202.11M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 19.56 |
| Book/Share | 9.46 |
| Cash/Share | 6.87 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | -267.01 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.88 |
| Quick ratio | 0.52 |